Status:
UNKNOWN
G-CSF and PRP in Patients With Recurrent Implantation Failure
Lead Sponsor:
Riyadh Fertility and Reproductive Health center
Conditions:
Infertility,Female
Eligibility:
FEMALE
1-35 years
Phase:
PHASE2
Brief Summary
The aim of this randomized controlled trial is to determine whether granulocyte colony-stimulating factor and platelet-rich plasma can be used to enhance the IVF-ET outcomes in patients with recurrent...
Eligibility Criteria
Inclusion
- • Patients with history of three or more unsuccessful IVF-ET cycles with at least 2 good quality embryos transferred
Exclusion
- Endometriosis
- Uterine anomalies
- Asherman syndrome
Key Trial Info
Start Date :
May 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2021
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT04411212
Start Date
May 28 2020
End Date
March 31 2021
Last Update
June 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Riyadh Fertility and Reproductive Health center
Giza, Egypt